title: Replication and meta-analysis of the gene-environment interaction between body mass index and the interleukin-6 promoter polymorphism with higher insulin resistance.
abstract: Insulin resistance (IR) is a complex disorder caused by an interplay of both genetic and environmental factors. Recent studies identified a significant interaction between body mass index (BMI) and the rs1800795 polymorphism of the interleukin-6 gene that influences both IR and onset of type 2 diabetes mellitus, with obese individuals homozygous for the C allele demonstrating the highest level of IR and greatest risk for type 2 diabetes mellitus. Replication of a gene-environment interaction is important to confirm the validity of the initial finding and extend the generalizability of the results to other populations. Thus, the objective of this study was to replicate this gene-environment interaction on IR in a hypertensive population and perform a meta-analysis with prior published results. The replication analysis was performed using white individuals with hypertension from the Hypertensive Pathotype cohort (N = 311), genotyped for rs1800795. Phenotype studies were conducted after participants consumed 2 diets--high sodium (200 mmol/d) and low sodium (10 mmol/d)--for 7 days each. Measurements for plasma glucose, insulin, and interleukin-6 were obtained after 8 hours of fasting. Insulin resistance was characterized by the homeostatic model assessment (HOMA-IR). In Hypertensive Pathotype, BMI was a significant effect modifier of the relationship between rs1800795 and HOMA-IR; higher BMI was associated with higher HOMA-IR among homozygote CC individuals when compared with major allele G carriers (P = .003). Furthermore, the meta-analysis in 1028 individuals confirmed the result, demonstrating the same significant interaction between rs1800795 and BMI on HOMA-IR (P = 1.05 × 10(-6)). This rare replication of a gene-environment interaction extends the generalizability of the results to hypertension while highlighting this polymorphism as a marker of IR in obese individuals.
authors.affiliation: Division of Endocrinology, Diabetes, and HTN, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. punderwood1@partners.org
authors.forename: Patricia C
authors.initials: PC
authors.lastname: Underwood
authors.forename: Bindu
authors.initials: B
authors.lastname: Chamarthi
authors.forename: Jonathan S
authors.initials: JS
authors.lastname: Williams
authors.forename: Bei
authors.initials: B
authors.lastname: Sun
authors.forename: Anand
authors.initials: A
authors.lastname: Vaidya
authors.forename: Benjamin A
authors.initials: BA
authors.lastname: Raby
authors.forename: Jessica
authors.initials: J
authors.lastname: Lasky-Su
authors.forename: Paul N
authors.initials: PN
authors.lastname: Hopkins
authors.forename: Gail K
authors.initials: GK
authors.lastname: Adler
authors.forename: Gordon H
authors.initials: GH
authors.lastname: Williams
mesh_terms: D001786:Blood Glucose / Q000378:metabolism; D015992:Body Mass Index; D004777:Environment; D005260:Female; D006706:Homeostasis; D006801:Humans; D007328:Insulin / Q000097:blood; D007333:Insulin Resistance / Q000235:genetics* / Q000502:physiology*; D015850:Interleukin-6 / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000235:genetics; D010641:Phenotype; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011401:Promoter Regions, Genetic / Q000235:genetics*
chemical_list: D001786:Blood Glucose; D007328:Insulin; D015850:Interleukin-6
references.citation: J Clin Endocrinol Metab. 2004 Apr;89(4):1885-90
references.pmid: 15070960
references.citation: J Hypertens. 2010 Jul;28(7):1459-65
references.pmid: 20589975
references.citation: Diabetes. 2000 Mar;49(3):517-20
references.pmid: 10868978
references.citation: Metabolism. 2011 Aug;60(8):1150-7
references.pmid: 21306748
references.citation: J Clin Endocrinol Metab. 2004 Oct;89(10):5053-8
references.pmid: 15472205
references.citation: Metabolism. 2007 Dec;56(12):1643-8
references.pmid: 17998015
references.citation: Diabetologia. 2005 Feb;48(2):251-60
references.pmid: 15645209
references.citation: Bioinformatics. 2010 Sep 1;26(17):2190-1
references.pmid: 20616382
references.citation: J Clin Invest. 1998 Oct 1;102(7):1369-76
references.pmid: 9769329
references.citation: JAMA. 2001 Jul 18;286(3):327-34
references.pmid: 11466099
references.citation: Exp Gerontol. 2006 Aug;41(8):737-45
references.pmid: 16797905
references.citation: J Hypertens. 2010 May;28(5):1020-6
references.pmid: 20216091
references.citation: J Clin Hypertens (Greenwich). 2006 Nov;8(11):791-6
references.pmid: 17086019
references.citation: Rev Physiol Biochem Pharmacol. 2003;149:1-38
references.pmid: 12687404
references.citation: Metabolism. 2011 Jul;60(7):965-8
references.pmid: 21036373
references.citation: Ann Med. 2009;41(2):128-38
references.pmid: 18752089
references.citation: Nat Rev Immunol. 2011 Feb;11(2):98-107
references.pmid: 21233852
references.citation: Diabetes. 2003 Feb;52(2):558-61
references.pmid: 12540635
references.citation: Mol Genet Metab. 2007 Apr;90(4):422-8
references.pmid: 17123852
references.citation: Metabolism. 2010 Dec;59(12):1801-8
references.pmid: 20619428
references.citation: Metabolism. 2010 Jan;59(1):144-51
references.pmid: 19765782
references.citation: J Clin Endocrinol Metab. 2010 Sep;95(9):E75-9
references.pmid: 20631015
references.citation: Obesity (Silver Spring). 2006 Aug;14(8):1454-61
references.pmid: 16988089
references.citation: Diabetologia. 1985 Jul;28(7):412-9
references.pmid: 3899825
references.citation: Ann Clin Biochem. 2010 Jul;47(Pt 4):343-9
references.pmid: 20592333